Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Category

Skin Cancer

Jun 24
Love2
Journal of Drugs in Dermatology JDD Article Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey

Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
Neoadjuvant Hedgehog Inhibitors: Gaining Ground in Mohs for BCC? A recent survey of American College of Mohs Surgery members reveals that 22% of Mohs surgeons are already using hedgehog pathway…
Read More
Jun 23
Love11

Dermatology Roundup: Drug Class Effective Against Treatment-Resistant Melanoma

By Nadia Marcus JDD Highlights, JDD in the Media, Skin Cancer, The Latest
Researchers at NYU Langone Health and the Perlmutter Cancer Center have discovered why many patients with melanoma are resistant to current treatments and how an existing drug class is effective…
Read More
May 19
Love1
Journal of Drugs in Dermatology JDD Article About Cutaneous Immune-Related Adverse Events Associated With Immunotherapy in Patients With Melanoma

Cutaneous Immune-Related Adverse Events Associated With Immunotherapy in Patients With Melanoma

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
What Skin Toxicities May Signal in Melanoma Patients on Immunotherapy Cutaneous immune-related adverse events (irCAEs) are among the most common side effects seen in patients receiving immune checkpoint inhibitors (ICIs)…
Read More
May 17
Love2
Journal of Drugs in Dermatology JDD Article About The Comparison Between Conventional Photodynamic Therapy and “Painless” Photodynamic Therapy in the Treatment of Actinic Keratosis: A Mini Review

The Comparison Between Conventional Photodynamic Therapy and “Painless” Photodynamic Therapy in the Treatment of Actinic Keratosis: A Mini Review

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
Painless™ PDT vs. Conventional PDT: A Quick Look at Patient Comfort in AK Treatment Actinic keratosis (AK) is one of the most common conditions treated by dermatologists, and photodynamic therapy…
Read More
May 16
Love1
Journal of Drugs in Dermatology JDD Article About Exploring the Scope of Melanoma Educational Content on Instagram

Exploring the Scope of Melanoma Educational Content on Instagram

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
Melanoma Education on Instagram: What’s Missing—Especially for Skin of Color As melanoma rates rise, with a projected 7.3% increase in new cases and 3.8% rise in mortality in 2024, the…
Read More
May 15
Love1
Journal of Drugs in Dermatology JDD Article About Squamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery

Squamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
What to Expect When Treating SCC In Situ with Mohs Surgery While squamous cell carcinoma in situ (SCCIS) is typically considered a low-risk skin cancer, treatment decisions, especially around surgical…
Read More
May 14
Love1
Journal of Drugs in Dermatology JDD Article About Endocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review

Endocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
EMPSGC: Why Mohs Might Be the Better Choice Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is rare, low-grade, and slow-growing—but it’s not without risk. Though uncommon, recurrence and even distant…
Read More
May 06
Love3
Journal of Drugs in Dermatology JDD Article About The Impact of Geographic Dermatologist Density on Melanoma Mortality

The Impact of Geographic Dermatologist Density on Melanoma Mortality

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
Melanoma Mortality Drops Where Dermatologists Are in High Supply: Read the Data New data shows a powerful link: the more dermatologists in your area, the lower your risk of dying…
Read More
Apr 30
Love3
Journal of Drugs in Dermatology JDD Article About Surgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review

Surgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
Cylindrocarcinoma: Could Mohs Surgery Be the Clear-Cut Winner? Cylindrocarcinoma—a rare malignant offshoot of benign cylindromas—poses a surgical challenge due to its potential for recurrence and metastasis. While traditional excision has…
Read More
Feb 24
Love0
Journal of Drugs in Dermatology JDD Article About Neoadjuvant Sonidegib for the Management of Locally Advanced Basal Cell Carcinoma: A Case Report

Neoadjuvant Sonidegib for the Management of Locally Advanced Basal Cell Carcinoma: A Case Report

By Nadia Marcus Featured Articles, Latest News, Skin Cancer, The Latest
Sonidegib for laBCC: A Neoadjuvant Game Changer? Neoadjuvant Hedgehog Pathway Inhibitors (HPIs) are reshaping the approach to locally advanced basal cell carcinoma (laBCC), but tolerability remains a concern. A recent…
Read More
Feb 17
Love0
Journal of Drugs in Dermatology JDD About Cancer Prevention Month. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone nose or face with a pigmented basal cell carcinoma.

February: National Cancer Prevention Month

By Nadia Marcus JDD Highlights, Latest News, Skin Cancer, The Latest
A Spotlight on Skin Health As February unfolds, so does an important reminder—this month is National Cancer Prevention Month. For dermatologists, it's a time to reinforce awareness, education, and proactive…
Read More
Jan 24
Love0
Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous adverse events that prevent our patients from having their chemo cake and eating it, too. Never fear as the supportive oncoderms are here….well just two, podcast host Dr. Adam Friedman and guest Dr. Jonathan Leventhal, Associate Professor of Dermatology, the Dermatology Residency Program Director and Director of the Oncodermatology Clinic at the Yale Cancer Center. Curl up with your favorite blanket and learn about the most recent multidisciplinary-guided algorithm for preventing and managing cutaneous targeted therapy related adverse events in cancer patients (as one does). From erosive stomatitis to other dermatologic complications, this podcast is packed with actionable insights to ensure your patients can focus on fighting cancer without unnecessary setbacks. You are going to want to listen up!

Treat to (Stay on) Target(ted Therapies)

By Nadia Marcus Featured Articles, Featured Podcast, Podcast Highlights, Skin Cancer, The Latest
Featured Podcast Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous…
Read More
NextPrevious »

Advertisement

Dermatology Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color

Advertisement

Top News Stories

  • Alopecia Areata in Skin of Color: Trichoscopic Analysis in Black/African American Patients July 21, 2025
  • Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage July 20, 2025
  • Probiotics Supplementation Improves Quality of Life, Clinical Symptoms, and Inflammatory Status in Patients With Psoriasis July 19, 2025
  • Broad-Spectrum & Visible Light Photoprotection Strategies for Diverse Patients – from Basic Science to Product Innovation July 18, 2025
  • One Size Doesn’t Fit All: Rethinking Atopic Dermatitis Through a Broader Lens July 17, 2025

CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search